shed new light on the molecular subtyping of breast cancer, a key factor in both diagnosis and the prescription of precise systemic treatments. This study meticulously peels back the layers of breast ...
This strategic alliance brings together the longstanding oncology diagnostic experience of Myriad Genetics and the clinical and translational research expertise of MD Anderson to create a portfolio of ...